Mr. Mutthuraj Dasegowda | Cancer Biology | Young Researcher Award

🎓 Education 

💼 Experience 

Mutthuraj D’s academic and research experience spans molecular biology, pharmacognosy, and cancer biology, starting with his M.Sc. project at JSS AHER (2018–2019) focused on ginger nanoparticle synthesis for arthritis therapy. He currently serves as a Junior Research Fellow exploring Moringa-based anticancer therapeutics. His technical expertise includes nanoparticle characterization, PCR, microscopy, ELISA, phytochemical analysis, and molecular diagnostics. As a Guest Faculty, he has taught undergraduate and postgraduate students, delivering lectures on molecular biology, pharmacology, and biochemistry. Mutthuraj actively contributes to peer-reviewed journals as a reviewer and assistant editor, including Taylor & Francis and Sparkling Press. He has also participated in scientific event organization, research seminars, and student mentorship. His hands-on research, manuscript writing, conference presentations, and patent contributions demonstrate a well-rounded skill set. He consistently integrates laboratory innovation with community health perspectives, making him a capable and collaborative biomedical researcher and educator.

🏆 Awards and Honors 

Mutthuraj D received the Best Article of the Issue award for his publication on COVID-19 in Acta Scientific Pharmacology (2020), reflecting his contribution to pandemic-related awareness. In January 2025, he was awarded the Junior Research Fellowship (JRF) by JSS AHER for academic excellence and innovative research in epigenetics and cancer biology. He is credited as an inventor in two Indian patents—on a UHPLC device for plasma drug estimation and a hot plate analgesiometer for stress studies in animals—demonstrating his contributions to lab instrumentation and translational research. He has been actively involved as an editorial board member and reviewer for multiple international journals and is affiliated with prestigious organizations such as the American Society for Microbiology (ASM), American Association for Cancer Research (AACR), and Alberta Society of Professional Biologists (ASPB). His awards recognize his research impact, scientific innovation, and commitment to molecular and clinical sciences.

🔬 Research Focus 

Mutthuraj D’s research focuses on exploring the therapeutic potential of plant-derived bioactive compounds in cancer and inflammatory diseases. His current PhD research at JSS AHER investigates the anti-cancerous effects of Moringa oleifera in epithelial ovarian cancer, targeting the PI3K/AKT/mTOR signaling pathway. His broader research interests encompass phytochemicals, chemoprevention, neurobiology, rheumatoid arthritis, and epigenetics. He has synthesized and characterized ginger-based nanoparticles for anti-inflammatory therapy, integrating nanotechnology and traditional medicine. His studies have evaluated immune biomarkers, inflammatory proteins (CRP, ASO), and haemolytic assays to validate herbal therapeutics. Additionally, his work includes bioinformatics modeling, molecular docking, and pathway analysis, aiming to understand the molecular mechanisms underlying natural product efficacy. With multiple peer-reviewed publications and conference presentations, he contributes to scientific discussions on green therapeutics, cancer modulation, and biomedical innovation. His ultimate goal is to develop cost-effective, plant-based alternatives to conventional cancer therapies with minimized toxicity and enhanced cellular response.